Delivery Order SPE2DB22D1202-SPE2DB25FVFE0
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for Pertzye DR 16,000 unit capsules, with a ceiling value of $31,175.38. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 4, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,735.52 to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s on July 24, 2025, with completion expected by July 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement for federal medical needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This delivery order, awarded on July 24, 2025, represents a $4,046.28 firm fixed-price purchase of Pertzye (pancrelipase) 16,000 unit capsules in quantities of 100 capsules, issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain. The contract is a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 25, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Pertzye is a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,818.10, is for the delivery of 24,000 units of the drug PERTZYE DR 24,000 UNIT CAPSULE UU 80S. The contract has an ultimate completion date of July 14, 2025. The award is not set aside and was open to full and open competition. Amerisourcebergen Drug Corp is the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of PERTZYE DR with a ceiling value of $20,343.60. This contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 15, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $8,136.80 with a firm fixed price for the delivery of 24,000 units of the medication PERTZYE DR 80S capsule. The contract has an ultimate completion date of July 18, 2025 and was awarded on July 17, 2025. This contract award is not designated as a set-aside....
- This federal contract award, valued at $13,179.68, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract, with an ultimate completion date of October 12, 2023, is for the delivery of 8,000 units of the medication Pertzye DR capsules. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. This contract is part of a larger Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 16,000 units of PERTZYE DR 100S capsules, with a firm fixed price ceiling value of $24,368.76. The ultimate completion date for this delivery order is May 27, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,144.30 firm fixed price delivery order contract is for the supply of 24,000 units of the prescription drug PERTZYE DR 200S. The contract has an ultimate completion date of July 3, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor...
- This delivery order, valued at $1,040.74, was awarded on August 15, 2025, to AmerisourceBergen Drug Corp for pharmaceutical and medical supply provision under a Defense Logistics Agency (DLA) contract. The award was issued without a set-aside designation on a firm fixed-price basis, with performance occurring at the contractor's Conshohocken, Pennsylvania location. Funding originated from the Defense Medical Supply Chain, reflecting ongoing federal procurement needs for pharmaceutical products...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFE0Delivery Order
This delivery order, valued at $11,363.52, was awarded on July 22, 2025, to AmerisourceBergen Drug Corp for the supply of 24,000 unit capsules of Pertzye 80s. The award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, with a place of performance in Conshohocken, Pennsylvania. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of July 23, 2025. No set-aside designation was applied to this award, indicating it was competitively procured. This delivery order functions as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company, a major pharmaceutical distributor and critical federal medical procurement vendor, holds a significant role in supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with essential medications and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 7/22/25 |